Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Presurgical models can effectively and affordably screen cancer prevention agents.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Finasteride use may increase suicidality risk, especially in young men.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

The document concludes that aging can be tackled by either slowing it down or eliminating its root cause.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Implementing safety strategies is crucial to prevent radiation-related health issues.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.